Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HMS, formerly known as HMS Holdings Corp., is a leading provider of cost containment and payment integrity solutions in the healthcare industry. The company primarily serves government and commercial healthcare payers, including Medicaid agencies, managed care organizations, and employer-sponsored health plans. HMS utilizes advanced data analytics and proprietary technology to identify and recover improper payments, coordinate benefits, and improve population health outcomes. In April 2021, the company was acquired by Gainwell Technologies, a portfolio company of Veritas Capital, for approximately $3.4 billion. Today, its capabilities are integrated into Gainwell's broader suite of healthcare technology offerings aimed at optimizing the efficiency of the U.S. healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HMS Healthcare.